GI SYMPTOMS IN COVID-19 INFECTION: the described symptoms suggest that parasympathetic dysautonomia might be result of the coronavirus pathophysiology.
Anosmia and headache are also reported as common premonitory symptoms, and these bespeak of central neurological dysfunction; perhaps at brainstem level.
The endocannabinoid system is intimately involved in neural synaptic neurotransmitter functions. Based on symptom pattern of COVID-19, Cannabis Sativa, which imparts sympathomimetic effects (as opposed to Indica, which is parasympathomimetic) might ameliorate COVID-19 symptoms.
An effective preparation might be a butter or coconut oil eluted concoction rendered at less than 180 degrees so as to avoid decarboxylation and conversion of THC-A to THC; thereby avoiding much of the psychotropic effects; then ingesting the medicinal or taking as suppository.
@threadreaderapp unroll
